Bcl-2 Expression Inhibits Liver Carcinogenesis and Delays the Development of Proliferating Foci
- 1 May 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 160 (5), 1555-1560
- https://doi.org/10.1016/s0002-9440(10)61101-7
Abstract
No abstract availableKeywords
Funding Information
- NIEHS (ES0 1247)
This publication has 25 references indexed in Scilit:
- Bcl-2 expression delays hepatocyte cell cycle progression during liver regenerationOncogene, 2002
- Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis)Carcinogenesis: Integrative Cancer Research, 2000
- Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic miceOncogene, 1999
- Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse modelOncogene, 1999
- Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regressionHepatology, 1997
- Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.The Journal of Experimental Medicine, 1996
- Apoptosis and multistage carcinogenesis in rat liverMutation Research, 1995
- Rapid development of hepatic tumors in transforming growth factor α transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbitalCarcinogenesis: Integrative Cancer Research, 1994
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988
- Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promotersCarcinogenesis: Integrative Cancer Research, 1984